1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Btk inhibitor 2 | Btk inhibitor 2 | 1558036-85-3 |
| BMS-935177 | 1231889-53-4 | 1231889-53-4 |
| Vecabrutinib | 维卡布鲁替尼 | 1510829-06-7 |
| SB 290157 (trifluoroacetate salt) | 1140525-25-2 | 1140525-25-2 |
| Cinacalcet | 西那卡塞 | 226256-56-0 |
| Cinacalcet HCl | 盐酸甲状旁腺激素 | 364782-34-3 |
| Suvecaltamide | MK-8998 | 953778-58-0 |
| NS-638 | 150493-34-8 | 150493-34-8 |
| trans-Ned 19 | 化合物 T12205L | 1354235-96-3 |
| TTA-Q6 | 910484-28-5 | 910484-28-5 |
| TTA-Q6(isomer) | TTA-Q6(isomer) | 910484-32-1 |
| Sunvozertinib | DZD 9008 | 2370013-12-8 |
| (S)-Sunvozertinib | 2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]- | 2370013-49-1 |
| Luxeptinib | CG-806 | 1616428-23-9 |
| Mirogabalin besylate | 10928苯磺酸盐 | 1138245-21-2 |
| Drotaverine hydrochloride | 盐酸屈他维林 | 985-12-6 |
| Pinaverium bromide | 匹维溴铵 | 53251-94-8 |
| BMS-986142 | BMS986142 | 1643368-58-4 |
| Branebrutinib | BMS-986195 | 1912445-55-6 |
| ARQ 531 | ARQ-531 | 2095393-15-8 |
| BTK inhibitor 10 | BTK inhibitor 10 | 2241732-30-7 |
| Orelabrutinib | 奥布替尼 | 1655504-04-3 |
| Pirtobrutinib | LOXO-305 | 2101700-15-4 |
| (R)-Pirtobrutinib | (R)-PIRTOBRUTINIB | 2101700-14-3 |
| SJF620 | SJF620 | 2376187-16-3 |
| TL-895 | 2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-4-fluoro-1-piperidinyl]- | 1415823-49-2 |
| BIIB091 | 1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-(1,1-DIMETHYLETHYL)-N-[(5R)-2,3,4,5-TETRAHYDRO-8-[2-[(1-METHYL-1H-PYRAZOL-4-YL)AMINO]-4-PYRIMIDINYL]-2-(3-OXETANYL)-1H-2-BENZ | 2247614-80-6 |
| Acalabrutinib | 阿卡替尼 | 1420477-60-6 |
| Spebrutinib | AVL292 | 1202757-89-8 |
| RN486 | RN 486 | 1242156-23-5 |
| ONO-4059 analog | 6-氨基-7,9-二氢-9-[(3S)-1-(1-氧代-2-丙烯-1-基)-3-哌啶基]-7-(4-苯氧基苯基)-8H-嘌呤-8-酮 | 1351635-67-0 |
| Fenebrutinib | GDC-0853 | 1434048-34-6 |
| PCI 29732 | 4-氨基-1-环戊基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶 | 330786-25-9 |
| BIIB068 | BIIB068 | 1798787-27-5 |
| TAK-020 | 化合物TAK-020 | 1627603-21-7 |
| Tirabrutinib | 替拉鲁替尼 | 1351636-18-4 |
| Fantofarone | 泛托法隆 | 114432-13-2 |
| Tirabrutinib hydrochloride | ONO-4059 (HYDROCHLORIDE) | 1439901-97-9 |
| Flunisolide | 氟尼缩松 | 3385-03-3 |
| DPH | 5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 | 484049-04-9 |
| BODIPY564/570carboxylicacid | BODIPY564/570羧酸 | 150173-89-0 |
| BODIPYFLcarboxylicacid | BODIPYFL羧酸 | 165599-63-3 |
| BODIPYFLNHSester | BODIPYFLNHS活化酯 | 146616-66-2 |
| BODIPYR6Gcarboxylicacid | BODIPYR6G羧酸 | 174881-57-3 |
| BDP TMR NHS ester | BODIPYTMRNHS活化酯 | 485397-12-4 |
| MK-5046 | 5MG | 1022152-70-0 |
| Neuromedin B (porcine) | GLY-ASN-LEU-TRP-ALA-THR-GLY-HIS-PHE-MET-NH2 | 87096-84-2 |
| Lys-[Des-Arg9]Bradykinin TFA | 化合物LYS-[DES-ARG9]BRADYKININ,TFA | 2763588-90-3 |
| Des-Arg9]-Bradykinin acetate | [DES-ARG9]-缓激肽 乙酸盐 水合物 | 23827-91-0 |
| Bradykinin (1-7) | 舒缓激肽片段1-7 | 23815-87-4 |
| Bradykinin (1-5) | ARG-PRO-PRO-GLY-PHE | 23815-89-6 |
| Bradykinin (2-9) | Bradykinin (2-9) | 16875-11-9 |
| Ibrutinib-biotin | 1599432-18-4 | 1599432-18-4 |
| Dihydrodiol-Ibrutinib | 依鲁替尼代谢物 | 1654820-87-7 |
| (±)-Zanubrutinib | (±)-赞鲁替尼 | 1633350-06-7 |
| Zanubrutinib | 泽布替尼 | 1691249-45-2 |
| Pitavastatin-d4 | Pitavastatin-d4 | 2070009-71-9 |
| ASTX660 | ASTX660 | 1799328-86-1 |
| APG-1387 | APG-1387 | 1570231-89-8 |
| NSC 15364 | 1,3-二(4-氨基苯基)脲 | 4550-72-5 |
| Azilsartan | 阿齐沙坦 | 147403-03-0 |
| Amiloride hydrochloride | 盐酸阿米洛利 | 2016-88-8 |
| Omaveloxolone | NRF1-ACTIVATOR-1 | 1474034-05-3 |
| Bosutinib hydrate | 博舒替尼一水化合物 | 918639-08-4 |
| Nilotinib-d6 | 尼罗替尼-D6 | 1268356-17-7 |
| BV02 | 2-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID | 292870-53-2 |
| Asciminib | ABL-001 | 1492952-76-7 |
| Asciminib hydrochloride | 阿思尼布盐酸盐 | 2119669-71-3 |
| LXH254 | LXH254 | 1800398-38-2 |
| Ponatinib-d8 | 纳替尼-D8 | 1562993-37-6 |
| GMB-475 | GMB-475 | 2490599-18-1 |
| Rebastinib | N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 | 1020172-07-9 |
| Olverembatinib | GZD824 | 1257628-77-5 |
| Olverembatinib dimesylate | GZD824DIMESYLATE | 1421783-64-3 |
| GNF-5 | GNF-5 | 778277-15-9 |
| Bafetinib | 巴氟替尼 | 859212-16-1 |
| XL228 | N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺 | 898280-07-4 |
| (S)-ML753286 | 1699720-85-8 | 1699720-85-8 |
| ML230 | ML233 | 1776055-05-0 |
| YHO-13351 free base | 912288-64-3 | 912288-64-3 |
| Ac32Az19 | 2760674-72-2 | |
| Elacridar | 依克立达 | 143664-11-3 |
| PTC209 HBr | PTC-209HBR | 1217022-63-3 |
| BODIPY558/568NHSester | BODIPY558/568NHS活化酯 | 150173-73-2 |
| BODIPY558/568carboxylicacid | BODIPY558/568羧酸 | 150173-72-1 |
| (E)-Ferulic acid-d3 | 阿魏酸-D3 | 860605-59-0 |
| Mirodenafil dihydrochloride | 米罗那非二盐酸盐 | 862189-96-6 |
| S116836 | 化合物 T24751 | 1257628-57-1 |
| Lometrexol hydrate | 洛美曲索水合物 | 1435784-14-7 |
| Z-Asp-CH2-DCB | CASPASE-1 INHIBITOR V ;Z-VAL-ALA-ASP(OME)-FLUOROMETHYLKETONE | 153088-73-4 |
| Estramustine phosphate sodium | 雌莫司汀磷酸钠 | 52205-73-9 |
| Takinib | 1111556-37-6 | 1111556-37-6 |
| Eragidomide | CC-90009 | 1860875-51-9 |
| Bz 423 | 216691-95-1 | 216691-95-1 |
| PDK4-IN-1 hydrochloride | PDK4-IN-1 HYDROCHLORIDE | 2310262-11-2 |
| RRx-001 | RRX-001 | 925206-65-1 |
| BMS-1 | PD-1 | 1675201-83-8 |
| LDN-57444 | LDN-57444 | 668467-91-2 |
| OR-1896 | 左西孟旦杂质 | 220246-81-1 |
| Eprenetapopt | APR-246 | 5291-32-7 |
联系方式
